ChromoGenics AB provides glass products that control heat and light transmission in Sweden.
+ 3 more risks
Mediocre balance sheet and overvalued.
Share Price & News
How has ChromoGenics's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CHRO's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: CHRO underperformed the Swedish Building industry which returned -5.6% over the past year.
Return vs Market: CHRO underperformed the Swedish Market which returned -9.7% over the past year.
Price Volatility Vs. Market
How volatile is ChromoGenics's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StThe Director of ChromoGenics AB (STO:CHRO), Anders Brännström, Just Bought 100% More Shares
1 month ago | Simply Wall StChromoGenics (STO:CHRO) Shareholders Received A Total Return Of -42% In The Last Year
2 months ago | Simply Wall StDo Insiders Own Lots Of Shares In ChromoGenics AB (STO:CHRO)?
Is ChromoGenics undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate CHRO's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate CHRO's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: CHRO is unprofitable, so we can't compare its PE Ratio to the Building industry average.
PE vs Market: CHRO is unprofitable, so we can't compare its PE Ratio to the Swedish market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CHRO's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CHRO is good value based on its PB Ratio (1.5x) compared to the SE Building industry average (2.1x).
How is ChromoGenics forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Capital Goods industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as ChromoGenics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Take a look at our analysis of CHRO’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- ChromoGenics competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Capital Goods industry.
How has ChromoGenics performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CHRO is currently unprofitable.
Growing Profit Margin: CHRO is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: CHRO is unprofitable, and losses have increased over the past 5 years at a rate of -16% per year.
Accelerating Growth: Unable to compare CHRO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CHRO is unprofitable, making it difficult to compare its past year earnings growth to the Building industry (11.3%).
Return on Equity
High ROE: CHRO has a negative Return on Equity (-182.73%), as it is currently unprofitable.
How is ChromoGenics's financial position?
Financial Position Analysis
Short Term Liabilities: CHRO's short term assets (SEK50.0M) exceed its short term liabilities (SEK41.7M).
Long Term Liabilities: CHRO's short term assets (SEK50.0M) exceed its long term liabilities (SEK47.8M).
Debt to Equity History and Analysis
Debt Level: CHRO's debt to equity ratio (116.4%) is considered high.
Reducing Debt: CHRO's debt to equity ratio has reduced from 538.7% to 116.4% over the past 5 years.
Inventory Level: CHRO has a high level of physical assets or inventory.
Debt Coverage by Assets: CHRO's debt is covered by short term assets (assets are 1x debt).
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CHRO has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: CHRO has less than a year of cash runway if free cash flow continues to reduce at historical rates of -26.7% each year
What is ChromoGenics's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CHRO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate CHRO's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CHRO's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CHRO's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CHRO's dividend in 3 years as they are not forecast to pay a notable one for the Swedish market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Jerker Lundgren (55yo)
Mr. Jerker Lundgren was Founder and Chief Executive Officer of Skandinaviska Glassystem AB since 1994. Mr. Lundgren has 20+ years of experience within the construction and glass industry, including project ...
|CEO & Director||1.83yrs||no data||no data|
|Co-Founder & CTO||no data||no data||no data|
|CFO & Head of Communications||1.17yrs||no data||no data|
|Chief Operating Officer||3.25yrs||no data||0.44% SEK281.5k|
Experienced Management: CHRO's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
|CEO & Director||1.83yrs||no data||no data|
|Chairman of the Board||0.83yr||no data||no data|
|Director||2.83yrs||no data||no data|
|Director||no data||kr133.00k||1.08% SEK684.1k|
|Director||2.83yrs||no data||no data|
|Director||0.83yr||no data||no data|
Experienced Board: CHRO's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: CHRO insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 472.2%.
ChromoGenics AB's company bio, employee growth, exchange listings and data sources
- Name: ChromoGenics AB
- Ticker: CHRO
- Exchange: OM
- Founded: 2003
- Industry: Building Products
- Sector: Capital Goods
- Market Cap: kr63.375m
- Shares outstanding: 402.38m
- Website: https://www.chromogenics.com
Number of Employees
- ChromoGenics AB
- Ullforsgatan 15
- Uppsala County
- 752 28
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|CHRO||OM (OMX Nordic Exchange Stockholm)||Yes||Common Stock||SE||SEK||Mar 2017|
|384||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Mar 2017|
|CHRO BTA||OM (OMX Nordic Exchange Stockholm)||NPV BTA 052020||SE||SEK||Mar 2020|
ChromoGenics AB provides glass products that control heat and light transmission in Sweden. It offers dynamic and static glasses, and colored solar facades. It markets its products under the ConverLight name. The company was founded in 2003 and is headquartered in Uppsala, Sweden.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/03/31 00:35|
|End of Day Share Price||2020/03/30 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.